Why Going to a Psychiatrist and not a PCP is so dang important

New Topic Post Reply Printable Version
[ << Previous Thread | Next Thread >> ]

Veteran Member

Date Joined May 2007
Total Posts : 3715
   Posted 9/1/2008 6:56 PM (GMT -7)   
Astonishing 52 Percent Of Newly Diagnosed Bipolar Disorder Patients Receive Antidepressant Drugs In First-Line Treatment
12 Aug 2008

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that an astonishing 52.3 percent of newly diagnosed bipolar disorder patients are prescribed antidepressant drugs first line. The new report entitled Treatment Algorithms in Bipolar Disorder finds that this high preponderance of early-line antidepressant use stems from primary care physician prescribing. Surveyed primary care physicians specify selective serotonin reuptake inhibitors (including Forest Laboratories' Lexapro) as a favored first-line treatment choice for patients with bipolar disorder I with acute depression (51 percent of surveyed physicians), bipolar disorder II with acute depression without hypomania (52 percent of surveyed physicians) and bipolar disorder II with acute depression with hypomania (46 percent of surveyed physicians).

"The number of primary care physicians who are diagnosing and treating bipolar patients has been on the rise in the past few years, but surveyed primary care physicians follow a very different treatment pattern than surveyed psychiatrists," said Madhuri Borde, Ph.D., analyst at Decision Resources. "Nearly half of the patients taking selective serotonin reuptake inhibitors first line receive these drugs as a monotherapy, despite guideline recommendations to give bipolar patients presenting with depression an antimanic first line."

The report also finds that GlaxoSmithKline's Lamictal is the leading single-agent in first-, second- and third-line therapy amassing 18 percent, 13.8 percent and 16.3 percent patient share in each line of therapy, respectively. Lamictal's accumulation of patient share in early lines of therapy is driven by psychiatrists' belief that this therapy is effective for patients with bipolar depression.

The majority of surveyed psychiatrists prefer Lamictal for first-line treatment of patients with bipolar disorder I with acute depression (59 percent of surveyed psychiatrists) and bipolar disorder II with acute depression and no hypomania (61 percent of surveyed psychiatrists). Lamictal and Abbott's Depakote ER are frequently prescribed first line by surveyed psychiatrists for bipolar disorder II patients who present with acute depression and hypomania (45 percent and 32 percent of surveyed psychiatrists, respectively).

about Treatment Algorithm Insight Series

Decision Resources combines in-depth primary research with the most extensive claims-based longitudinal patient-level data from PharMetrics(R) to provide exceptional insight into physicians' prescribing trends and the factors that drive therapy product choice, from diagnosis through multiple courses of treatment, for a specific disease.

For each disease examined, Decision Resources' Treatment Algorithm Insight Series provides the following:

-- Summary of United States medical practice based on interviews with leading experts in the field

-- Qualitative diagnosis/referral/treatment algorithm for the United States

-- Drug usage by lines of therapy (1st, 2nd, 3rd line)

-- Discussion of key freeform combinations by lines of therapy

-- Product share (class and specific compound level) within each line of therapy (1st, 2nd, 3rd line)

-- Progression of therapy from key 1st line products

-- Pathway to key therapies from previous therapies

-- Qualitative analysis of two-year forecast incorporating upcoming launches, changes in reimbursement, etc.

about Decision Resources

Decision Resources (http://www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

Decision Resources

Article URL: http://www.medicalnewstoday.com/articles/117914.php

Main News Category: Bipolar
Co-Moderator, Bipolar Forum
Bipolar II

Veteran Member

Date Joined May 2008
Total Posts : 1081
   Posted 9/3/2008 4:18 PM (GMT -7)   
Thank-you Sarafena. Here's what I see: My grandmother's mother's life was cut short as she was released from hospital prematurely. My grandmother had to move to the woods and limit contact with people, period, My mother, herself a psychiatrist (stating "since I'll be spending my life in a mental institution, I'm going to have a set of keys"') is certifiable and thank goodness, no longer practicing, except on us, my youngest sister, treated with SSRI's only is psychotic, my brother was put on Effexor by a primary care physician, is six four and very strong, went on a rampage which scared me and my aging Dad half to death as I thought he was going to kill me, I myself, now a rapid cycler, breaking down in tears ten or more times a day due to taking only Zoloft (an SSRI) only prescribed by Front lines PCP. I can no longer work, I was a social worker but it's hard to help others when you, yourself are a mess. I actually got fired from three cleaning jobs, and also from a recycling depot. Imagin that eh? That's where ex-cons work sucessfully, how sick do you have to be to get fired from a job, sorting garbage?
New Topic Post Reply Printable Version
Forum Information
Currently it is Monday, January 22, 2018 7:23 AM (GMT -7)
There are a total of 2,920,027 posts in 320,404 threads.
View Active Threads

Who's Online
This forum has 159444 registered members. Please welcome our newest member, John765.
495 Guest(s), 11 Registered Member(s) are currently online.  Details
Fear, 81GyGuy, PeterDisAbelard., cashlessclay, Godisgr8, searchinginla, ejc61, testuser1234, Cubby, John765, iPoop